CV CapsoVision Forecast, Technical & Fundamental Analysis
CapsoVision Inc is a commercial-stage medical technology enterprise that innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system... Show more
CV is expected to report earnings to fall 26.67% to -10 cents per share on August 13
Q2'26
Est.
$-0.11
Q1'26
Missed
by $0.04
Q4'25
Missed
by $0.06
The last earnings report on May 14 showed earnings per share of -15 cents, missing the estimate of -10 cents. With 78.94K shares outstanding, the current market capitalization sits at 310.77M.
A.I.dvisor tells us that CV and QDEL have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CV and QDEL's prices will move in lockstep.
CV's RSI Oscillator recovers from oversold territory
The RSI Oscillator for CV moved out of oversold territory on July 08, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 4 similar instances when the indicator left oversold territory. In of the 4 cases the stock moved higher. This puts the odds of a move higher at .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CV advanced for three days, in of 49 cases, the price rose further within the following month. The odds of a continued upward trend are .
CV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on July 07, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CV as a result. In of 17 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for CV turned negative on July 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 7 similar instances when the indicator turned negative. In of the 7 cases the stock turned lower in the days that followed. This puts the odds of success at .
CV moved below its 50-day moving average on July 06, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CV crossed bearishly below the 50-day moving average on July 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 2 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for CV entered a downward trend on July 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (15.361) is normal, around the industry mean (11.208). P/E Ratio (0.000) is within average values for comparable stocks, (65.302). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.948). CV has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.017). P/S Ratio (22.831) is also within normal values, averaging (25.206).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
